FLT3LG and hepatocellular carcinoma: FLT-3L promotes DC proliferation and enhances antitumor immunity through in situ vaccination strategies, such as adenoviral vectors expressing FLT-3L, which have been shown to potentiate radiation therapy and induce Th1 immune response in HCC models [129].